SCHEMBL31733550

SCHEMBL31733550

C[C@H](N)c1cc2c(cc1O)CCCN2C(=O)C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.44
▸ CA2 P00918 2/20 0.44
▸ CA7 P43166 2/20 0.44
▸ CA9 Q16790 2/20 0.44
▸ CA12 O43570 1/20 0.44
▸ PDK1 Q15118 11/20 0.38
▸ PDK2 Q15119 11/20 0.38
▸ PDK3 Q15120 11/20 0.38
▸ PDK4 Q16654 11/20 0.38
▸ CYP11B2 P19099 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ CA14 Q9ULX7 1/20 0.34
▸ OPRM1 P35372 1/20 0.34
▸ OPRD1 P41143 1/20 0.34
▸ OPRK1 P41145 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31733591 0.80 CA1 (0.38) CA1CA2CA7CA9CA12
SCHEMBL31733731 0.79 PDK1 (0.45) CA1CA2CA7CA9CA12
SCHEMBL10238670 0.73 PDK1 (0.47) CA1CA2CA7CA9CA12
SCHEMBL4425315 0.71 BRD4 (0.63) CA1CA2CA7CA9CA12
SCHEMBL12476172 0.71 CA1 (0.56) CA1CA2CA7CA9CA12
SCHEMBL13041657 0.71 ALDH1A1 (0.51) CA1CA2CA7CA9CA12
SCHEMBL19465749 0.71 RORC (0.51) CA1CA2CA7CA9CA12
SCHEMBL31733772 0.70 CA12 (0.39) CA1CA2CA7CA9CA12
SCHEMBL31733487 0.70 CA12 (0.39) CA1CA2CA7CA9CA12
SCHEMBL2616853 0.69 CA12 (0.44) CA1CA2CA7CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025237891-A1 QUINOLINE-2-CARBOXAMIDE DERIVATIVES AS RAD51 INHIBITORS FOR THE TREATMENT OF CANCER NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2025-11-20 — — WO disclosed
Send feedback